The recommended dose is 0.66 mg/kg bodyweight administered once weekly by subcutaneous injection.
24mg Pen (20mg/ml)
60mg Pen (50mg/ml)
Suggested for doses less than 12mg
Suggested for doses 12mg and above
Based on growth velocity, adverse reactions, body weight and serum insulin-like growth factor 1(IGF-1) concentrations. Note: When monitoring IGF-1, samples should always be drawn 4 days after prior dose.
For full dosing details, refer to the Summary of Product Characteristics for NGENLA.
Before first use
After first use
Prior to the first use, NGENLA may be stored for 3 years at 2–8°C in a refrigerator.
After first use, NGENLA may be stored for 28 days in a refrigerator (2 °C – 8 °C).
NGENLA is administered by the pre-filled, multi-dose, disposable UnoPen – giving patients and caregivers the confidence to administer treatment and get back to moments that matter.
NGENLA is to be injected in the abdomen, thighs, buttocks or upper arms. The site of injection should be rotated at each administration. Injections to the upper arms and buttocks should be given by the caregiver.
• Administer NGENLA once weekly, on the same day each week, at any time of the day.
• The day of weekly administration can be changed if necessary as long as the time between 2 doses is at least 3 days (>72 hours).
• If a dose is missed, NGENLA should be administered as soon as possible within 3 days of the missed dose; then the usual once-weekly dosing schedule should be resumed. After 3 days of missed dose, the dose should be skipped and the next dose administered on the regular scheduled day.
Sterile needles are required for administration but are not included in the NGENLA pack.
NGENLA can be administered with a needle from 4mm to 8mm and 31G or 32G.
Pfizer will provide a box of needles as standard within the patient starter box:
- BD Micro-Fine Ultra 4mm 32G needles (quantity 100)
For resupply, or to order additional or different needles at no cost, the patient/caregiver or Healthcare Professional can contact the Endocrine Helpline on 0800 521249 or [email protected]
Find out information about the starter kits available to patients starting treatment with NGENLA.
Download the document to access information supporting fomulary application for NGENLA.
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
OK, We will need you to sign in before we can determine if you are aligned with a Pﬁzer promotional colleague.This is an interstitial message to prompt a HCP before they login.
If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.
Would you like to register or sign in now?